ClinicalTrials.gov
ClinicalTrials.gov Menu

CMAB vs IMAB in Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00255268
Recruitment Status : Withdrawn
First Posted : November 18, 2005
Last Update Posted : August 28, 2007
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given